Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial

PaperCitations, authors & open-access status

Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 34 citations, 2025 year and hybrid oa status.

34
Citations
2025
Year
hybrid
OA Status

Related on ScholarIQ

Adèle Hesters
Author
The Lancet
Journal
Amyotrophic Lateral Sclerosis Research
Topic
Amyotrophic Lateral Sclerosis Research
Topic
Multiple Sclerosis Research Studies
Topic
Genetic Neurodegenerative Diseases
Topic
470M+ articles · free account